about
Role of Extracellular Vesicles and microRNAs on Dysfunctional Angiogenesis during Preeclamptic PregnanciesRegulatory RNAs controlling vascular (dys)function by affecting TGF-ß family signallingVascular repair strategies in type 2 diabetes: novel insightsIn situ Detection of MicroRNAs: The Art of MicroRNA Research in Human Diseases.Mother's Pre-pregnancy BMI and Placental Candidate miRNAs: Findings from the ENVIRONAGE Birth Cohort.'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy.Association Between Coronary Artery Disease and MicroRNA: Literature Review and Clinical PerspectiveEnvironmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view.The future of pleiotropic therapy in heart failure. Lessons from the benefits of exercise training on endothelial function.Mir-351-5p contributes to the establishment of a pro-inflammatory environment in the H9c2 cell line by repressing PTEN expression.microRNA profiling in atherosclerosis, diabetes, and migraine.Molecular mechanism of miR-181b in heart disease due to pregnancy-induced hypertension syndrome.Circulating endothelial microparticles and miR-92a in acute myocardial infarctionComparison of protocols and RNA carriers for plasma miRNA isolation. Unraveling RNA carrier influence on miRNA isolation.The Influence of Extracellular RNA on Cell Behavior in Health, Disease and Regeneration.Genistein Protects Against Ox-LDL-Induced Inflammation Through MicroRNA-155/SOCS1-Mediated Repression of NF-ĸB Signaling Pathway in HUVECs.MicroRNA profiling in migraine without aura: pilot study.MiR-154 directly suppresses DKK2 to activate Wnt signaling pathway and enhance activation of cardiac fibroblasts.The Potential Role of Platelet-Related microRNAs in the Development of Cardiovascular Events in High-Risk Populations, Including Diabetic Patients: A Review.Deferoxamine stimulates LDLR expression and LDL uptake in HepG2 cells.A systems biology network analysis of nutri(epi)genomic changes in endothelial cells exposed to epicatechin metabolites
P2860
Q26752382-C7DF98A8-1F58-4CEE-93E9-C92ED3377607Q26767134-59AEFDA6-9C40-4A6D-8E0A-B8D1BBB13566Q26778658-69F50A03-D5F8-444F-8B84-0FA595E1E6F2Q33699616-0830AA93-9AAB-4AD2-BC2C-CC6DDBA1564AQ33911774-E79C1635-08EF-4CB5-9411-AE73AE38F3D9Q37159985-ED6C1EFF-0AF4-4769-974F-FC12D796DE0DQ38661848-1ACA9F50-488C-47AB-A429-D15078829B5CQ38679562-BDD1FD99-3A6D-40FE-AA71-5C46192B3527Q38682574-83CB08F8-CDE7-4DCF-AD0E-F6D00E654452Q38768191-DDB301A4-0131-4141-8CF0-AED582427B90Q38821745-CC9481E7-97AE-4EC4-8242-EB41C0381E5CQ38827929-9A7A9E36-0103-4E8C-A82E-C9668DD1C466Q41624580-14DC20F6-40DC-4F19-A636-0397C6A6347AQ42074198-D34D251A-A4B1-4C6B-93A9-6A06182304DEQ43412551-5691A875-216E-41ED-B7BA-17F746D918AFQ47931462-30A8134A-7BE9-46EA-8CEA-3CA88AAE2180Q50976249-E335B034-0B41-437A-B102-9E3CB00C809BQ50989062-6F31DBF4-B95F-4373-A8EA-D3DB845354F8Q51561512-9CE587B5-ADFE-48A3-8DD0-0267FE0973C2Q52608599-CDDAA36D-7313-4905-8019-77AD08195582Q53280634-7184AC46-A2AB-410B-9164-74A359AFCDA5Q57811403-3C59CBD6-5298-4F38-8290-08021095D6E7
P2860
description
scientific article published on 01 February 2015
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2015
@uk
name
MicroRNAs and cardiovascular diseases
@en
MicroRNAs and cardiovascular diseases
@nl
type
label
MicroRNAs and cardiovascular diseases
@en
MicroRNAs and cardiovascular diseases
@nl
prefLabel
MicroRNAs and cardiovascular diseases
@en
MicroRNAs and cardiovascular diseases
@nl
P2860
P921
P356
P1476
MicroRNAs and cardiovascular diseases
@en
P2093
Takashi Akasaka
P2860
P304
P356
10.1155/2015/682857
P407
P5008
P577
2015-02-01T00:00:00Z